Download PDF
Dtsch Med Wochenschr 2013; 138(09): 437-440
DOI: 10.1055/s-0032-1332885
Prinzip & Perspektive | Review article
Onkologie
© Georg Thieme Verlag KG Stuttgart · New York

Kinasen und Phosphatasen: Schlüsselenzyme in der gezielten Krebstherapie

Kinases and phosphatases: key enzymes in targeted cancer therapy
M. Schulze
1   Rudolf-Virchow-Zentrum, DFG Forschungszentrum für Experimentelle Biomedizin
,
A. Gohla
1   Rudolf-Virchow-Zentrum, DFG Forschungszentrum für Experimentelle Biomedizin
2   Institut für Pharmakologie und Toxikologie der Universität Würzburg
› Author Affiliations
Further Information

Publication History

06 September 2012

23 November 2012

Publication Date:
19 February 2013 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Gezielte Krebstherapie - Phosphorylierung - Kinasen - Phosphatasen

Keywords

targeted cancer therapy - phosphorylation - kinases - phosphatases
 

  • Literatur

  • 1 Bollen M, Peti W, Ragusa MJ et al. The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci 2010; 35: 450-458
    CrossrefPubMedGoogle Scholar
  • 2 Cook PJ, Ju BG, Telese F et al. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009; 458: 591-596
    CrossrefPubMedGoogle Scholar
  • 3 Galluzzi L, Vitale I, Senovilla L et al. Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer. Cell Rep 2012; 2: 257-269
    CrossrefPubMedGoogle Scholar
  • 4 Gohla A, Birkenfeld J, Bokoch GM. Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics. Nat Cell Biol 2005; 7: 21-29
    CrossrefPubMedGoogle Scholar
  • 5 Julien SG, Dube N, Hardy S et al. Inside the human cancer tyrosine phosphatome. Nat Rev Cancer 2011; 11: 35-49
    CrossrefPubMedGoogle Scholar
  • 6 Olsen JV, Blagoev B, Gnad F et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127: 635-648
    CrossrefPubMedGoogle Scholar
  • 7 Possemato R, Marks KM, Shaul YD et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476: 346-350
    CrossrefPubMedGoogle Scholar
  • 8 Sefton BM, Hunter T, Beemon K et al. Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 1980; 20: 807-816
    CrossrefPubMedGoogle Scholar
  • 9 Seifried A, Schultz J, Gohla A. Human HAD phosphatases: structure, mechanism, and roles in health and disease. FEBS J 2012; doi: DOI: 10.1111/j.1742-4658.2012.08633.x.
    PubMedGoogle Scholar
  • 10 Tadjuidje E, Wang TS, Pandey RN et al. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone. PLoS One 2012; 7: e34806
    CrossrefPubMedGoogle Scholar
  • 11 Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006; 7: 833-846
    CrossrefPubMedGoogle Scholar
  • 12 Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 1988; 263: 6722-6730
    PubMedGoogle Scholar
  • 13 Vintonyak VV, Antonchick AP, Rauh D et al. The therapeutic potential of phosphatase inhibitors. Curr Opin Chem Biol 2009; 13: 272-283
    CrossrefPubMedGoogle Scholar
  • 14 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674
    CrossrefPubMedGoogle Scholar